The science-based clinical trial supply specialists with a truly global footprint
Clinical Services International (CSI) is a global leader in the sourcing and management of quality certified commercially available medicines – comparators, concomitant drugs and rescue medication – for clinical trials. Headquartered in London, we have offices in the United Kingdom, Germany and the United States. With an international network of over 95 manufacturers and depots spanning six continents, we have worldwide access and global project management expertise, sourcing medicines from Europe, the United States, Central and South America, and Asia Pacific.
With over 25 years of experience in intelligent sourcing and clinical trial supply, our team are in an unrivalled position to deliver bespoke strategies and efficient solutions to support any study, even with the most complex requirements. Our fully integrated services reduce timelines and costs, ultimately accelerating drug development.
Who We Are
What makes us different?
We bring a scientific emphasis to all aspects of clinical trial supply.
When you partner with CSI, you can trust that our science-based team have relevant degree-level qualifications. By leveraging our academic knowledge and in-depth understanding of clinical trial design and protocols, we can confidently provide advice, quality assurance and ensure secure delivery, allowing trials to run on time and provide better patient outcomes.
Focus
We work solely in the field of clinical trial supply
Accountability
CSI’s governance structure ensures success and savings
Skilled
Our data-driven approach minimises wastage, delays and disruption
Trust
Fostering longstanding relationships with our partners is a key priority
Experience
We have 25+ years’ experience in sourcing and regulatory requirements
Reach
We have access to 100+ manufacturers and audited local suppliers
Transparency
Our short supply chains have transparency and accountability at their core
Economy
Our sourcing structure delivers cost-effective solutions for our partners
Science
We can interpret protocol requirements and provide tailor-made solutions
Track record
We have supplied 1,000+ trials and have never failed to deliver
Ten reasons CSI is the ideal partner for your global clinical trial supply requirements:
What Makes Us Different?
We bring a scientific emphasis to all aspects of clinical trial supply. When you partner with CSI, you are partnering with a science-based team with relevant degree level qualifications. By leveraging our academic knowledge and direct understanding of clinical trial design and protocols, we can confidently offer quality assurance and delivery, allowing trials to run on time and provide better patient outcomes.
Ten reasons why CSI is the best partner for your global clinical trial supply needs:
Focus – We work only in clinical trial supply
Accountability – Our governance structure ensures success and savings
Skilled – Our data-driven approach minimises wastage, delays and disruption
Trust – Fostering longstanding relationships with our partners is a key priority
Experience – We have over 25 years’ experience in comparator sourcing and regulatory requirements
Reach – We have access to more than 100 manufacturers and audited local suppliers
Transparency – We design a short supply chain, with transparent services and accountability at its core
Economy – Our sourcing structure delivers the most cost-effective solutions for our partners
Science – Our team’s scientific expertise allows us to interpret protocol requirements and provide tailor-made solutions
Track record – We have supplied over 1,000 trials and have never failed to deliver
Leadership
With over 25 years of experience in clinical trial design and supply, the CSI leadership team’s scientific knowledge is at the heart of all the services we offer. We understand the complexities involved in sourcing the most appropriate medication for your study and pride ourselves on offering tailor-made solutions to even the most complex of trial requirements. Our science-based approach, coupled with our operational expertise and global reach, allows us to efficiently and ethically specify, source and supply comparators and medical devices for any clinical trial.
_edited.jpg)
Dr Vanessa Dekou
Vanessa started her career as a research associate at Scotland Yard and later joined LGC Group. She subsequently joined IQVIA, where she worked with some of the world’s largest biopharmaceutical and biotech companies to provide innovative solutions. She has extensive experience in drug development from preclinical to registration and commercialisation strategies, and has secured product registration for several orphan and first-in-class drugs. She was also Chief Commercial Officer of a leading technology provider for patient access to clinical trials.
Vanessa was Senior Advisor to DiGamma Capital. She is on the Enterprise Advisory Board of CW+ (the charity of Chelsea and Westminster Hospital NHS Foundation Trust), the Board of the Judge Business School, University of Cambridge, and undertakes extensive charity work. She has a PhD in Cardiovascular Genetics from University College London (UCL), an MBA from the University of Cambridge and a master’s degree in Market Access from the University of Lyon.
Managing Director
London
London
Vanessa Dekou
Managing Director
Vanessa started her career as a research associate at Scotland Yard and later joined LGC Group. Subsequently, she joined IQVIA, where she worked with some of the world’s largest biopharmaceutical and biotech companies to provide innovative solutions. She has extensive experience in drug development from preclinical to registration and commercialisation strategies. She has secured product registration for several orphan and first-in-class drugs. She was also Chief Commercial Officer of a leading technology provider for patient access to clinical trials.
Vanessa was Senior Advisor to DiGamma Capital. She is on the Enterprise Advisory Board of CW+ (the charity of Chelsea and Westminster Hospital NHS Foundation Trust), the Board of the Judge Business School, University of Cambridge, and undertakes extensive charity work. She has a PhD in Cardiovascular Genetics from University College London (UCL), an MBA from the University of Cambridge and a master’s degree in Market Access from the University of Lyon.
.jpg)
London
Maurizio Tassi
Finance Director
Maurizio has over 30 years’ experience in investment banking. He has interests and expertise in healthcare and a keen eye for early-stage innovative biotech and medtech companies.
Maurizio was on the boards of Molmed S.p.A. and Lay Line Genomics. Before joining CSI, he was a financial advisor of San Raffaele Hospital, Milan, and a fund manager of Luxembourg SICAV (Long-Short Strategy European stocks).
He started his career as Head of New Issues, Schroders, and subsequently Managing Director, Capital Markets, Citigroup. He is an Honorary Member of the Italian Medical Society of Great Britain. Maurizio earned his BSc in Anthropology from UCL, and his MSc in Economics from the London School of Economics (LSE).
.jpg)
Stephan Mütze
With more than 16 years’ experience in the pharmaceutical industry, Stephan heads CSI’s German office, supporting and managing supplies for complex studies across the world.
Before Stephan joined CSI, he held various positions in clinical operations and supply chain management for leading companies. With his combined clinical and logistical background, he is adept at consulting and guiding our partners, ensuring their projects have successful and efficient outcomes. His pragmatic and hands-on approach, as well as his deep knowledge of Good Distribution Practice (GDP) and Good Manufacturing Practice (GMP) regulations, are some of his most valued strengths.
Associate Director Project Management and Prokurist
Berlin
Jean Bowtell
Jean has over 15 years of experience in the pharmaceutical industry, specializing in comparator sourcing and clinical trial supplies. Jean is leading CSI’s US business operations and is responsible for driving strategic growth and expanding our market presence. Jean’s global expertise in supporting Phase I-IV clinical trials enables her to deliver tailored solutions that meet the unique needs of each study.
Prior to joining CSI, Jean led the clinical trial sourcing division at Clinigen, and worked at a global Contract Research Organization (CRO), giving her a deep understanding of client needs and industry challenges. With a Bachelor’s degree in both Biology and Psychology from Rutgers University, Jean combines her science-driven approach with a passion for advancing life-saving medicines and optimizing efficiency.
Executive Vice President
United States
Andrea is responsible for strategy and business development, driving CSI’s international expansion in the United States and East Asia, and building partnerships with our top clients. He has over 25 years’ professional experience in strategy, business development, corporate finance and investment banking. Andrea has advised corporate clients on a wide range of strategic and transformational projects, including mergers and acquisitions (M&A), partnerships, initial public offerings (IPOs), privatisations and international expansion across a number of sectors and jurisdictions. He has also been involved in start-ups, both as an investor and a founder.
Andrea previously worked for JPMorgan Cazenove, McKinsey, and Booz Allen & Hamilton. He is an Honorary Fellow of Bayes Business School, University of London.
.jpg)
London
Andrea Giochetta
Director of Strategy & Business Development
With more than 16 years’ experience in the pharmaceutical industry, Stephan heads up our German office, supporting and managing supplies for complex studies across the world.
Before Stephan joined CSI, he held various positions in clinical operations and supply chain management for leading companies. With his combined clinical and logistical background, he is adept at consulting and guiding our partners, ensuring their projects have successful and efficient outcomes.
His pragmatic and hands-on approach, coupled with his deep knowledge of Good Distribution Practice (GDP) and Good Manufacturing Practice (GMP) regulations, are some of his strengths most valued by our team and our global partners.
US City
Name
Title
Our Team
Safety & Security
I'm a paragraph. Click here to add your own text and edit me. It’s easy. Just click “Edit Text” or double click me to add your own content and make changes to the font.
Transparency
I'm a paragraph. Click here to add your own text and edit me. It’s easy. Just click “Edit Text” or double click me to add your own content and make changes to the font.
Growth & Innovation
I'm a paragraph. Click here to add your own text and edit me. It’s easy. Just click “Edit Text” or double click me to add your own content and make changes to the font.
Quality
-min.jpeg)
Sustainability
CSI is EcoVadis certified with a Platinum Award, a globally recognised benchmark for sustainability in the supply chain. We recognise the importance of sustainable and ethical procurement – for our business model, as well as the planet – and aim to set ourselves apart in the clinical trial supply industry as a transparent and adaptive company. We ensure that all our suppliers are audited and qualified against important criteria, such as environmental compliance
What we value
-
Our Global Reach
Warehouses and offices
Our network extends to 60 countries on six continents
Quality
Sourcing and distributing medicines and medical devices around the world requires extensive knowledge of regional regulations that differ from country to country. CSI’s independent and well-established quality department ensures global regulatory compliance across all our processes and safeguards the quality of every product we supply to a clinical trial. Our regulatory and quality assurance experts have longstanding relationships with MHRA and EMA and can provide expert advice and bespoke solutions.
We ensure
-
Timeliness of medicine supplies
-
Consistency and reliability of investigational medicines
-
Traceability throughout our supply chain
-
Comprehensive documentation and record-keeping
.jpg)
We comply with
-
Falsified Medicines Directive (FMD)
-
Good Distribution Practice (GDP)
-
Good Manufacturing Practice (GMP)
-
Good Storage Practice (GSP)
We offer
-
Country-specific regulatory expertise
-
Highest standards of quality and safety
-
Relationships with regulatory agencies
-
Independent quality department
We can provide
-
Certificates of Analysis (CofAs)
-
Batch Release Certificates (BRCs)
-
Statements of Authenticity (SofAs)
CSI’s science-based approach to clinical trial supply aims to improve the downstream life sciences industry, helping to make new and safe medicines rapidly available to patients
Innovation
We work closely with partners and stakeholders who share our values and build lasting relationships with them based on mutual trust and being the best service provider we can be
Collaboration
CSI is proud to operate with honesty and transparency, maintaining the highest ethical standards and upholding the regulations and procedures required in all aspects of our business
Integrity
We keep up with evolving industry standards in compliance, logistics and supply chain management. Quality is in our DNA and it is aligned with all our strategic objectives
Quality
.jpg)
Maurizio Tassi
Maurizio has over 30 years’ experience in investment banking. He has interests and expertise in healthcare and a keen eye for early-stage innovative biotech and medtech companies. He has been on the boards of Molmed S.p.A. and Lay Line Genomics. Before joining CSI, he was a financial advisor of San Raffaele Hospital, Milan, and a fund manager of Luxembourg SICAV (Long-Short Strategy European stocks).
Maurizio started his career as Head of New Issues, Schroders, and subsequently Managing Director, Capital Markets, Citigroup. He is an Honorary Member of the Italian Medical Society of Great Britain. Maurizio earned his BSc in Anthropology from UCL, and his MSc in Economics from the London School of Economics (LSE).
Director of Finance and Legal
London
.jpg)
Andrea Giochetta
Andrea is responsible for strategy and business development, driving CSI’s international expansion in the United States and East Asia, and building partnerships with our top clients.
He has over 25 years’ professional experience in strategy, business development, corporate finance and investment banking. Andrea has advised corporate clients on a wide range of strategic and transformational projects, including mergers and acquisitions (M&A), partnerships, initial public offerings (IPOs), privatisations and international expansion across a number of sectors and jurisdictions. He has also been involved in start-ups, both as an investor and a founder. Andrea previously worked for JPMorgan Cazenove, McKinsey, and Booz Allen & Hamilton. He is an Honorary Fellow of Bayes Business School, University of London.
Director of Strategy and Business Development
United Kingdom and United States
.jpg)
Michael Vertheim
Michael has over 20 years of multi-disciplinary experience in business management, business development, product marketing and growth, and has held directorial positions in the global technology sector. He specialises in software development, data analysis and its application to business solutions.
He received his BA in Economics and Management (specialising in Information Technology) from the Academic College of Tel Aviv–Yaffo (MTA).
Head of Business Development
Tel Aviv
.jpg)
Steven Girdlestone
Steve is a veteran of the pharmaceutical industry, having started his career at Pfizer in research, development and formulation of novel compounds. Subsequently, he worked as Head Pharmacist in some of the largest NHS Trust Hospitals in the UK, where he gained invaluable experience in stock control, manufacturing, clinical trials and validation procedures. Steve has since moved back to the pharmaceutical and manufacturing industry, where he has extensive expertise in all aspects of site quality and regulatory compliance (MHRA and ISO), third-party EUGMP audits, QP product release on MIA (IMP) licence, and acting as a Responsible Person and Quality Controller.
Steve is a Member of the Royal Pharmaceutical Society (RPS), Member of the General Pharmaceutical Council (GPhC) and Member of the Joint Pharmaceutical Analysis Group (JPAG). He is a qualified Pharmacist with BPharm (Hons) and has a Diploma in Psychiatric Pharmacy.
Qualified Person (QP) and Pharmacist
London
Get in touch with a member of our experienced team today to discuss your clinical trial supply requirements
Contact us
.png){kind=logo}